東峯集團(601515.SH):目前未涉及口含煙相關業務
格隆匯4月9日丨東峯集團(601515.SH)在投資者互動平台表示,公司目前未涉及口含煙相關業務。 目前公司業務涵蓋新型材料、I類醫藥包裝等產品的研發、設計、生產與銷售。歷經多年發展與產品結構的持續優化,公司產品涉及新能源隔膜、PET基膜、PVA高阻隔膜、PVC硬片、PVDC硬片、藥用包裝瓶、藥用玻璃管、藥用玻璃瓶、易刺鋁蓋、鋁塑組合蓋、藥用SP複合膜、藥用包裝鋁箔、成型衝壓複合硬片(包括冷衝壓成型鋁、熱帶型泡罩鋁)等多個產品品類,持續加大在新型材料及I類醫藥包裝領域的資金投入與資源佈局,並進一步提升對於核心業務的聚焦度,集中資金與資源確保核心業務板塊的提速發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.